World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
120
Citations
82867
World Ranking
3666
National Ranking
2022

Overview

Lewis J. Rubin is affiliated with the University of California, San Diego in the United States. Their research primarily focuses on medicine, with significant emphasis on pulmonary and respiratory medicine, cardiology and cardiovascular medicine, hepatology, genetics, and physiology.

Their investigations cover a range of topics including pulmonary hypertension research and treatments, heart failure treatment and management, liver disease and transplantation, cardiovascular function and risk factors, vascular anomalies and treatments, cardiovascular issues in pregnancy, and congenital heart disease studies.

Rubin has contributed several recent papers to the field, including:

  • The physiological basis of pulmonary arterial hypertension, 2021, European Respiratory Journal
  • Risk stratification and treatment goals in pulmonary arterial hypertension, 2024, European Respiratory Journal
  • Intravascular Ultrasound Pulmonary Artery Denervation to Treat Pulmonary Arterial Hypertension (TROPHY1), 2020, JACC: Cardiovascular Interventions
  • The impact of comorbidities on selexipag treatment effect in patients with pulmonary arterial hypertension: insights from the GRIPHON study, 2021, European Journal of Heart Failure
  • Relationship Between Time From Diagnosis and Morbidity/Mortality in Pulmonary Arterial Hypertension, 2021, CHEST Journal

Frequent coauthors working alongside Rubin include:

  • Nazzareno Galiè
  • Richard N. Channick
  • Vallerie V. McLaughlin
  • Marius M. Hoeper
  • Iréne Lang

Their research has appeared largely in these publication venues:

  • European Respiratory Journal
  • Advances in Therapy
  • JACC Basic to Translational Science
  • Pulmonary Circulation
  • UNC Libraries

Best Publications

  • ACCF/AHA 2009 Expert Consensus Document on Pulmonary Hypertension: A Report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents and the American Heart Association: Developed in Collaboration With the American College of Chest Physicians, American Thoracic Society, Inc., and the Pulmonary Hypertension Association

    Vallerie V. McLaughlin;Stephen L. Archer;David B. Badesch;Robyn J. Barst

  • Bosentan therapy for pulmonary arterial hypertension.

    Lewis J. Rubin;David B. Badesch;Robyn J. Barst;Nazzareno Galiè

  • A Comparison of Continuous Intravenous Epoprostenol (Prostacyclin) with Conventional Therapy for Primary Pulmonary Hypertension

    Robyn J. Barst;Lewis J. Rubin;Walker A. Long;Michael D. McGoon

  • Sildenafil citrate therapy for pulmonary arterial hypertension.

    Nazzareno Galiè;Hossein A. Ghofrani;Adam Torbicki;Robyn J. Barst

  • Clinical classification of pulmonary hypertension

    Gerald Simonneau;Nazzareno Galiè;Lewis J Rubin;David Langleben

  • Inhaled iloprost for severe pulmonary hypertension.

    Horst Olschewski;Gerald Simonneau;Nazzareno Galiè;Timothy Higenbottam

  • Primary pulmonary hypertension.

    Lewis J. Rubin

  • Effects of the dual endothelin-receptor antagonist bosentan in patients with pulmonary hypertension: a randomised placebo-controlled study.

    Richard N Channick;Gérald Simonneau;Olivier Sitbon;Ivan M Robbins

  • Continuous subcutaneous infusion of treprostinil, a prostacyclin analogue, in patients with pulmonary arterial hypertension: a double-blind, randomized, placebo-controlled trial.

    Gerald Simonneau;Robyn J. Barst;Nazzareno Galie;Robert Naeije

  • Guidelines for the diagnosis and treatment of pulmonary hypertension

    Marius M. Hoeper;Marc Humbert;Adam Torbicki;Jean-Luc Vachiery

  • Macitentan and morbidity and mortality in pulmonary arterial hypertension.

    Tomás Pulido;Igor Adzerikho;Richard N. Channick;Marion Delcroix

  • Guidelines on diagnosis and treatment of pulmonary arterial hypertension. The Task Force on Diagnosis and Treatment of Pulmonary Arterial Hypertension of the European Society of Cardiology.

    Nazzareno Galiè;Adam Torbicki;Robyn Barst;Philippe Dartevelle

  • Riociguat for the Treatment of Pulmonary Arterial Hypertension

    Hossein-Ardeschir Ghofrani;Nazzareno Galiè;Friedrich Grimminger;Ekkehard Grünig

  • ACCF/AHA 2009 Expert Consensus Document on Pulmonary Hypertension

    Vallerie V. McLaughlin;Stephen L. Archer;David B. Badesch;Robyn J. Barst

  • Right Ventricular Function and Failure Report of a National Heart, Lung, and Blood Institute Working Group on Cellular and Molecular Mechanisms of Right Heart Failure

    Norbert F. Voelkel;Robert A. Quaife;Leslie A. Leinwand;Robyn J. Barst

  • Continuous intravenous epoprostenol for pulmonary hypertension due to the scleroderma spectrum of disease. A randomized, controlled trial.

    David B. Badesch;Victor F. Tapson;Michael D. McGoon;Bruce H. Brundage

  • Ambrisentan for the Treatment of Pulmonary Arterial Hypertension Results of the Ambrisentan in Pulmonary Arterial Hypertension, Randomized, Double-Blind, Placebo-Controlled, Multicenter, Efficacy (ARIES) Study 1 and 2

    Nazzareno Galiè;Horst Olschewski;Ronald J. Oudiz;Fernando Torres

  • Treatment of patients with mildly symptomatic pulmonary arterial hypertension with bosentan (EARLY study): a double-blind, randomised controlled trial

    N Galiè;LJ Rubin;MM Hoeper;P Jansa

  • Initial Use of Ambrisentan plus Tadalafil in Pulmonary Arterial Hypertension

    Nazzareno Galiè;Joan A. Barberà;Adaani E. Frost;Hossein-Ardeschir Ghofrani

  • Bosentan therapy for pulmonary arterial hypertension

    L.J. Rubin;D.B. Badesch;R.J. Barst

Frequent Co-Authors

Nazzareno Galiè
Nazzareno Galiè University of Bologna
Gérald Simonneau
Gérald Simonneau University of Paris-Saclay
Hossein Ardeschir Ghofrani
Hossein Ardeschir Ghofrani University of Giessen
Marius M. Hoeper
Marius M. Hoeper Hannover Medical School
Victor F. Tapson
Victor F. Tapson Duke University
Olivier Sitbon
Olivier Sitbon University of Paris-Saclay
David B. Badesch
David B. Badesch University of Colorado Denver
Adam Torbicki
Adam Torbicki Center for Postgraduate Medical Education at ECZ-Otwock
Marc Humbert
Marc Humbert University of Paris-Saclay
Jason X.-J. Yuan
Jason X.-J. Yuan University of California, San Diego

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For students interested in expanding their options beyond traditional medical programs, a variety of related online degrees and career pathways are available. Advancing from a Master of Science in Nursing (MSN) to a Doctor of Nursing Practice (DNP) is increasingly popular, with many msn to dnp programs online offering flexibility and affordability for working professionals.

Those considering a future in pharmacy can explore accredited online pharmacy school cost options, making this high-demand career pathway more accessible without the financial burden of on-campus programs.

Technology roles in healthcare are also growing rapidly. Obtaining a bachelor of health information management online can prepare students for positions that oversee vital patient data and electronic health records.

For those interested in the administrative side of medicine, medical billing and coding is a viable option. Curious about how much does it cost to become a medical coder? Online coursework offers an affordable and speedy route to certification.

These online degree programs are ideal for individuals seeking flexibility, lower tuition, and entry into diverse healthcare careers.

Best Scientists Citing Lewis J. Rubin

Trending Scientists